NONPROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NONPROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NONPROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NONPROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy shot aims to stop diabetic eye disease in its tracks
Disease control Recruiting nowThis study tests a one-time gene therapy called surabgene lomparvovec (Sura-vec) for diabetic retinopathy, a common eye problem from diabetes that can lead to blindness. About 576 adults with moderate-to-severe non-proliferative diabetic retinopathy will receive either the gene t…
Matched conditions: NONPROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug IGT-303 tested for safety in kidney disease patients
Symptom relief Recruiting nowThis study tests the safety of a new drug called IGT-303 in healthy volunteers and people with chronic kidney disease (CKD). About 94 participants will receive either the drug or a placebo, given as a shot under the skin or into a vein. Researchers will monitor for side effects t…
Matched conditions: NONPROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE1, PHASE2 • Sponsor: Ingenia Therapeutics INC • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC